• DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
DNDi - Best Science for the Most Neglected 20 Years
  • DNDi - Best Science for the Most Neglected 20 Years
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • COVID-19
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • HELP Helminth Elimination Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi Southern Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press releases

Swiss Malaria Group announces winners of malaria photo contest

Geneva, Switzerland — 22 Apr 2013
Share on twitter
Share on facebook
Share on linkedin
Share on email
Share on print

On the occasion of World Malaria Day 2013, the Swiss Malaria Group announce the winners of the photo contest “Malaria: The Big Picture”. The online photo contest and subsequent exhibition was organised by the Swiss Malaria Group to highlight the reality of those living at risk of malaria and the work of those dedicated to changing that reality.
[Click here to view the winning photos from each category][Français] [Deutsch]

Since 2000, thanks to the scale-up of malaria control measures, such as bed nets, insecticide spraying, diagnosis and effective medicines, the world has made major progress in reducing suffering and death associated with malaria. Many countries have been able to eliminate the disease from their borders. Endemic countries are making the commitment to control and eliminate malaria, and new tools and approaches are being developed to support this work. For the first time in history, defeating the disease altogether is within reach.

The fight against malaria has been one of our best investments in global health to date. Yet, these recent gains are increasingly threatened by a shortfall in funding. It is critically important that we pool all possible resources to stay the course, as malaria resurgence will remain a persistent threat until the disease is eradicated altogether.

To celebrate the gains and highlight the critical need to maintain the momentum, between 15 February and 24 March, photographers from around the world submitted more than 700 photos in three categories (people, healthcare & control, and research & development) to the contest. The public were then invited to vote before 7 April to determine a shortlist and the final winners were chosen by an international panel of judges.

First-place winners, selected by the judges, will receive a new Fuji camera and CHF 400 in cash. Runners-up, in second to fifth place, will receive one of a series of cash prizes: 2nd: CHF 400; 3rd: CHF 300; 4th: CHF 200; 5th: CHF 100.

“The competition is one of the strongest I have seen,” said David Burnett, one of the contest’s judges and three times World Press Photo jury member. “There is a wonderful combination of ‘reportage’ and portraits, and together they provide a very impressive selection of photographs highlighting the efforts to help people in malaria-infested locations. I’m happy to have been involved in judging; it’s really important to support photographers who are telling stories about malaria and bringing the issues of prevention and treatment into the public eye.”

“The Swiss Malaria Group thanks Fuji Switzerland for their generous donation of three cameras as first prizes, the fifteen organisations  that provided their promotional support and our expert jury panel for their selection,” said Dr Thomas Teuscher of Roll Back Malaria. “We hope that the contest will not only raise awareness about malaria but encourage other organisations to join the group and make it even stronger in the years to come.”

“Photos have the ability to open the door on a world never seen before,” Gerhard Siegfried, Head of East and Southern Africa Division of the Swiss Agency for Development and Cooperation. “Photos submitted to the contest have not only opened that door to malaria but have also allowed us to step through and see the bigger picture; the victims of malaria, the tools and interventions that can save them from the disease and the people working to develop those tools. I invite you to see the big picture for yourself.”

The Swiss Malaria Group will mark World Malaria Day 2013 and announce the winners at 18h00, 22 April 2013 at the Malaria Vaccines for the World conference in Lausanne, Switzerland, where the winning photos will be displayed. The winners and runners-up can also be viewed via the online exhibition from 22 April 2013.

Congratulations to our winners, which are as follows:

Category 1: People
1st: Dimple Pancholi: ‘Untitled’
2nd: Somenath Mukhopadhyay: ‘Look beyond’
3rd: Rabin Chakrabarti: ‘Preventing mosquito bites’
4th: Allan Jay Quesada: ‘Poverty and malaria risks’
5th: Fabian Biasio: ‘Children jumping into the water’

Category 2: Health care and control
1st: Sandipan Majumdar: ‘Malaria prevention’
2nd: Andre Laas: ‘The art of war’
3rd: Matthieu Zellweger: ‘Unpacking the net’
4th: Sarah Hoibak: ‘Spaceman? No, vector-man!’
5th: Oliver Lassen: ‘Two for one’

Category 3: Research and development
1st: Jennifer Jackson: ‘Bloodsuckers’
2nd: Konstantin Ikonomidis: ‘Thermal (un)comfort of a bed net’
3rd: Quique Bassat: ‘Looking for a patient’s missing file’
4th: Andre Laas: ‘Know the enemy’
5th: Ken Mwai: ‘See it large, see it minute’

Click here for more details about malaria, the fight to defeat it, and the winning photos

About the Swiss Malaria Group
Founded in 2007, the Swiss Malaria Group (SMG) comprises 17 organisations based in Switzerland, working to develop and deliver new tools to tackle malaria. By joining forces, the organisations are stronger and more effective. The goal is to raise awareness about the devastation wreaked by malaria and the work of Switzerland and other countries to defeat it. Synergies between the members contribute to the decline of malaria cases around the world through innovative control measures, knowledge and financial flows.

The Swiss Agency for Development and Cooperation leads the group, which includes:

• Acino Pharma AG
• Biovision
• Centre Hospitalier Universitaire Vaudois
• Drugs for Neglected Diseases initiative
• Foundation for Innovative New Diagnostics
• Medicines for Malaria Venture
• Medicus Mundi Schweiz
• Novartis
• Novartis Foundation for sustainable development
• Roll Back Malaria
• Swiss Malaria Foundation
• SoildarMed
• Swiss Red Cross
• Swiss Tropical and Public Health Institute
• Syngenta
• Vestergaard Frandsen

For more information about the SMG, please contact:
Susanna Hausmann
Email: susanna.hausmann@deza.admin.ch
Tel: 031 322 38 37
Mob: 076 579 99 65

For more information about the contest, please contact:
Elizabeth Poll
Email: polle@mmv.org
Tel: +41 22 799 45 81
Mob: +41 79 907 59 92

Malaria

Read, watch, share

Loading...
Davide Paparo and Ian Hausler with their thermotherapy device "CLARA"
Stories
16 Mar 2023

Cutaneous leishmaniasis: Swiss students develop innovative thermotherapy device for safer treatment of ‘flesh-eating parasite’

Stories
8 Mar 2023

Highlighting gender-based treatment gaps on International Women’s Day: Mary Alamak’s story

DNDi-GARDP Southern Africa director, Carol Ruffell (left), presents the December 2022 edition of HIV Nursing Matters and the 2022 paediatric ARV dosing chart to Bénédicte Schutz, Monaco’s Director of International Cooperation (centre), and Yordanos Pasquier, Monaco’s Deputy Director of International Cooperation (right).
News
3 Mar 2023

Working together to ensure optimal treatment for children living with HIV in South Africa

Nurse with patient
Press releases
1 Mar 2023

Fiocruz and DNDi sign strategic alliance agreement

Statements
28 Feb 2023

DNDi’s submission to the Technical Assessment component of the first Global Stocktake

Statements
22 Feb 2023

DNDi comments on the zero draft of the WHO CA+ for consideration of the Intergovernmental Negotiating Body at INB4 & 5

Hat Platform Newsletter N°22 screenshot
Publications
22 Feb 2023

HAT Platform Newsletter No. 22

Lab activities
News
20 Feb 2023

First in-person Dengue Alliance meeting brings together experts from dengue-endemic countries to develop treatments for a growing viral threat

VIEW ALL

Help neglected patients

To date, we have delivered twelve new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
DNDi - Best Science for the Most Neglected 20 Years
Facebook-f
Twitter
Instagram
Linkedin-in
Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License   
We use cookies to track our audience and improve our content. By clicking 'Accept All', you are agreeing to our use of cookies. Click on 'Customize' to accept only some cookies.
Customize
REJECT ACCEPT ALL
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-advertisement1 yearSet by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent1 yearRecords the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
PHPSESSIDsessionThis cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
CookieDurationDescription
elementorneverThis cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
CookieDurationDescription
_ga2 yearsThe _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_16Q5RH3XRG2 yearsThis cookie is installed by Google Analytics.
_gat_UA-10302561-11 minuteA variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid1 dayInstalled by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
_hjAbsoluteSessionInProgress30 minutesHotjar sets this cookie to detect the first pageview session of a user. This is a True/False flag set by the cookie.
_hjFirstSeen30 minutesHotjar sets this cookie to identify a new user’s first session. It stores a true/false value, indicating whether it was the first time Hotjar saw this user.
_hjIncludedInPageviewSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's pageview limit.
_hjIncludedInSessionSample2 minutesHotjar sets this cookie to know whether a user is included in the data sampling defined by the site's daily session limit.
_hjSession_112884430 minutesHotjar sets this cookie.
_hjSessionUser_11288441 yearHotjar sets this cookie.
CONSENT2 yearsYouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.
Targeting
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
SAVE & ACCEPT
Powered by CookieYes Logo